Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 50
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Entropy (Basel) ; 22(9)2020 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-33286801

RESUMO

We propose a new statistical observation scheme of diffusion processes named convolutional observation, where it is possible to deal with smoother observation than ordinary diffusion processes by considering convolution of diffusion processes and some kernel functions with respect to time parameter. We discuss the estimation and test theories for the parameter determining the smoothness of the observation, as well as the least-square-type estimation for the parameters in the diffusion coefficient and the drift one of the latent diffusion process. In addition to the theoretical discussion, we also examine the performance of the estimation and the test with computational simulation, and show an example of real data analysis for one EEG data whose observation can be regarded as smoother one than ordinary diffusion processes with statistical significance.

2.
Dig Dis Sci ; 64(9): 2538-2547, 2019 09.
Artigo em Inglês | MEDLINE | ID: mdl-30874990

RESUMO

BACKGROUND: Fibromyalgia (FM) is a disorder characterized by widespread chronic pain as core symptom and a broad range of comorbidities. Despite the prevalence of gastrointestinal (GI) comorbidities in patients with FM, GI functions have rarely been investigated in animal models of FM. AIMS: The purpose of the present study is to investigate the coexistence of alterations of GI function in the reserpine-induced myalgia (RIM) rat, a validated FM model associated with disruption of monoamine system. METHODS: Paw withdrawal threshold (von Frey hair test) was assessed as pain-associated indicator. Gastric emptying (13C breath test), small intestinal transit (charcoal meal test), and fecal water content were investigated as GI functions. RESULTS: The specific regimen of reserpine for the RIM rat, i.e., 1 mg/kg s.c., once daily for three consecutive days, caused a reduction of paw withdrawal threshold (i.e., mechanical allodynia) on days 3, 5, and 7 after the first injection. The 13CO2 excreted from the RIM rat was significantly increased on day 7. The RIM rat exhibited an acceleration of small intestinal transit on day 5. Fecal water content collected from the RIM rat was significantly increased on days 3 and 5. The amount of noradrenaline was significantly decreased in GI tissues on days 3, 5, and 7 in the RIM rat. Conclusions This study revealed that accelerated gastric emptying, accelerated small intestinal transit, and increase in fecal water content coexist with mechanical allodynia in the RIM rat, simulating the coexistence of chronic pain and alterations of GI function in patients with FM.


Assuntos
Fibromialgia/complicações , Trato Gastrointestinal/fisiopatologia , Hiperalgesia/complicações , Hiperalgesia/fisiopatologia , Animais , Temperatura Corporal , Colo/metabolismo , Modelos Animais de Doenças , Fezes/química , Fibromialgia/induzido quimicamente , Esvaziamento Gástrico , Mucosa Gástrica/metabolismo , Trânsito Gastrointestinal , Hiperalgesia/induzido quimicamente , Jejuno/metabolismo , Masculino , Norepinefrina/metabolismo , Limiar da Dor , Ratos , Ratos Sprague-Dawley , Reserpina , Tato , Água/análise
3.
Biosci Biotechnol Biochem ; 82(5): 862-868, 2018 May.
Artigo em Inglês | MEDLINE | ID: mdl-29504865

RESUMO

5-Hydroxytryptamine (5-HT) and noradrenaline have been thought to play important roles in the mechanism of hot flush. Then, to clarify the relation between serotonergic and adrenergic nervous systems on the mechanism of hot flush, the effect of paroxetine, 5-HT reuptake inhibitor (SSRI) was evaluated on the yohimbine-induced hot flush increase of tail skin temperature in ovariectomized female rats. Yohimbine (adrenaline α2 antagonist) significantly increased the tail skin temperature in course of time. Clonidine (adrenaline α2 agonist) significantly attenuated this effect. Paroxetine also significantly inhibited the increase of tail skin temperature by yohimbine. α-Lactalbumin having SSRI activity in vitro study also significantly inhibited the increase of tail skin temperature, but not significantly decreased the initial temperature. This difference may explain the different mechanism between paroxetine (SSRI) and α-lactalbumin, suggesting new mechanism of hot flush.

4.
Digestion ; 96(2): 92-102, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28768250

RESUMO

BACKGROUND/AIMS: Probiotics appear to improve Helicobacter pylori-associated dyspepsia via an inhibitory effect on H. pylori; however, uncertainty exists regarding their effects in H. pylori-uninfected individuals. We evaluated the efficacy of Lactobacillus gasseri OLL2716 (L. gasseri OLL2716) on H. pylori-uninfected individuals with functional dyspepsia (FD). METHODS: A double-blind, parallel-group, placebo-controlled, randomized, controlled trial was performed. Participants were randomly assigned to ingest L. gasseri OLL2716-containing yogurt (L. gasseri OLL2716 group) or L. gasseri OLL2716-free yogurt (placebo group) for 12 weeks. Participants completed questionnaires that dealt with a global assessment as well as symptom severity. The per-protocol (PP) population was evaluated for efficacy in accordance with a plan prepared beforehand. RESULTS: Randomization was performed on 116 individuals; the PP population consisted of 106 individuals (mean age 42.8 ± 9.0). The impressions regarding the overall effect on gastric symptoms were more positive in the L. gasseri OLL2716 group compared to that in the placebo group (statistical trend; p = 0.073). The elimination rate for major FD symptoms was 17.3 and 35.3% in the placebo and L. gasseri OLL2716 groups respectively (p = 0.048). CONCLUSION: L. gasseri OLL2716 has beneficial effects on FD without H. pylori involvement.


Assuntos
Dispepsia/terapia , Infecções por Helicobacter/terapia , Lactobacillus gasseri , Probióticos/uso terapêutico , Adulto , Método Duplo-Cego , Dispepsia/microbiologia , Feminino , Infecções por Helicobacter/microbiologia , Helicobacter pylori/isolamento & purificação , Humanos , Masculino , Pessoa de Meia-Idade , Inquéritos e Questionários , Resultado do Tratamento , Iogurte/microbiologia
5.
Biosci Biotechnol Biochem ; 81(10): 1941-1947, 2017 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-28752795

RESUMO

The present study was designed to evaluate the hepatoprotective potential of α-lactalbumin (αLA) against dimethylnitrosamine (DMN)-induced toxic insults in the rat liver. The liver damage was induced in rats by the repeated administration of DMN (10 mg/kg, i.p.) on three consecutive days per week for three weeks. The rats were maintained on either a standard AIN-93 M or αLA-enriched diet starting one week before the DMN injection until the termination of the experiment. The DMN treatment produced a progressive increase in the plasma markers (aspartate aminotransferase, alanine aminotransferase, total bililbin, hyarulonic acid, and matrix metalloproteinase-2) in 28 days after the first DMN injection. Dietary treatment with αLA significantly reduced the DMN-induced damage toward normalcy. NG-nitro-L-arginine methyl ester, a nitric oxide synthase inhibitor, significantly attenuated the hepatoprotective effect of αLA. These findings show that αLA has a marked suppressive effect on hepetic fibrosis through a nitric oxide-mediated mechanism.


Assuntos
Dimetilnitrosamina/farmacologia , Lactalbumina/química , Lactalbumina/farmacologia , Fígado/efeitos dos fármacos , Fígado/patologia , Leite/química , Óxido Nítrico/metabolismo , Alanina Transaminase/sangue , Animais , Aspartato Aminotransferases/sangue , Bovinos , Fibrose , Fígado/metabolismo , Masculino , Tamanho do Órgão/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Baço/efeitos dos fármacos , Baço/patologia
6.
Int J Sport Nutr Exerc Metab ; 26(1): 46-54, 2016 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-26252574

RESUMO

Although there have been many investigations of the beneficial effects of both exercise and amino acids (AAs), little is known about their combined effects on the single-dose ingestion of AAs for lipid metabolism during exercise. We hypothesize that taking a specific combination of AAs implicated in glucagon secretion during exercise may increase fat metabolism. We recently developed a new mixture, d-AA mixture (D-mix), that contains arginine, alanine, and phenylalanine to investigate fat oxidation. In a double-blind, placebo-controlled crossover study, 10 healthy male volunteers were randomized to ingest either D-mix (3 g/dose) or placebo. Subjects in each condition subsequently performed a physical task that included workload trials on a cycle ergometer at 50% of maximal oxygen consumption for 1 hr. After oral intake of D-mix, maximum serum concentrations of glycerol (9.32 ± 6.29 mg/L and 5.22 ± 2.22 mg/L, respectively; p = .028), free fatty acid level (0.77 ± 0.26 mEq/L and 0.63 ± 0.28 mEq/L, respectively; p = .022), and acetoacetic acid levels (37.9 ± 17.7 µmol/L and 30.3 ± 13.9 µmol/L, respectively; p = .040) were significantly higher than in the placebo groups. The area under the curve for glucagon during recovery was numerically higher than placebo (6.61 ± 1.33 µg/L · min and 6.06 ± 1.23 µg/L · min, respectively; p = .099). These results suggest that preexercise ingestion of D-mix may stimulate fat metabolism. Combined with exercise, the administration of AA mixtures could prove to be a useful nutritional strategy to maximize fat metabolism.


Assuntos
Alanina/administração & dosagem , Arginina/administração & dosagem , Suplementos Nutricionais , Exercício Físico/fisiologia , Metabolismo dos Lipídeos/efeitos dos fármacos , Fenilalanina/administração & dosagem , Estudos Cross-Over , Método Duplo-Cego , Teste de Esforço , Humanos , Masculino , Consumo de Oxigênio , Fenômenos Fisiológicos da Nutrição Esportiva , Adulto Jovem
7.
J Pharmacol Sci ; 127(2): 229-31, 2015 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-25727962

RESUMO

Gastric emptying has been known to correlate the pyloric sphincter contractile function and distention-induced gastric relaxation (gastric accommodation). In the present study, the effects of L-tryptophan on the gastric emptying and accommodation were evaluated by breath test using [1-(13)C]acetic acid and Barostat study, respectively, in rats. L-Tryptophan significantly decreased Cmax and AUC120min and delayed Tmax, indicating the inhibition of gastric emptying. L-Tryptophan significantly enhanced the gastric accommodation. These findings show that L-tryptophan may inhibit the gastric emptying through the enhanced gastric accommodation. Therefore, L-tryptophan may be useful for the therapy of postprandial dyspepsia, especially for early satiety.


Assuntos
Testes Respiratórios/métodos , Esvaziamento Gástrico/efeitos dos fármacos , Estômago/fisiopatologia , Triptofano/farmacologia , Animais , Técnicas de Diagnóstico do Sistema Digestório , Dispepsia/tratamento farmacológico , Dispepsia/fisiopatologia , Masculino , Manometria , Período Pós-Prandial , Ratos Sprague-Dawley , Triptofano/uso terapêutico
8.
J Pharmacol Sci ; 121(4): 299-304, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23538674

RESUMO

This study aimed to clarify the correlation between the estrous cycle and prevalence rate of endometriosis by sequential laparoscopy in Wistar-Imamichi female rats. The peritoneal implantation of endometrial tissue was performed in four estrous cycle rats (proestrus, estrus, metestrus, and diestrus). One week after implantation, the volume of the ectopic endometriosis was measured, and sequential laparoscopy was performed for 4 weeks to observe the prevalence rate. Five weeks after implantation, the volume of the ectopic endometriosis was measured again after laparoscopy. One week after implantation, the volume of endometriosis was significantly larger in proestrus and estrus rats than metestrus and diestrus rats. Prevalence rate was decreased with time. Five weeks after implantation, the prevalence rate and volume were higher and larger in the metestrus, diestrus, and estrus rats than in the proestrus rats. These results show that the estrous cycle affects the change of ectopic endometriosis. The decrease of prevalence rate was slow in metestrus, diestrus, and estrus rats as compared to that in proestrus rats. The volume of ectopic endometriosis showed little decrease with time when the endometrial tissue was implanted during the metestrus and diestrus portion of the cycle. Moreover, sequential laparoscopy made it possible to observe the prevalence rate of endometriosis.


Assuntos
Coristoma , Endometriose/epidemiologia , Endometriose/patologia , Endométrio/transplante , Ciclo Estral/fisiologia , Laparoscopia/métodos , Peritônio , Doenças Uterinas/epidemiologia , Doenças Uterinas/patologia , Animais , Endometriose/etiologia , Feminino , Prevalência , Ratos , Ratos Wistar , Fatores de Tempo , Doenças Uterinas/etiologia
9.
J Pharmacol Sci ; 121(4): 282-7, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23514789

RESUMO

Mosapride citrate hydrate (mosapride) has been known to act as a 5-HT4 agonist and to enhance gastric emptying. However, its mode of action, such as time course and dosage effect, on gastric emptying has not been clarified. This study aimed to clarify these points by the breath test using [1-(13)C]acetic acid in conscious rats. Mosapride significantly and dose-dependently enhanced the gastric emptying increased Cmax and AUC120 min at doses between 0.1 and 3 mg/kg. Pre-treatment with GR113808 (5-HT4 antagonist) significantly attenuated the enhancement of gastric emptying by mosapride. On the contrary, at a dose of 30 mg/kg, mosapride significantly inhibited the gastric emptying. The major metabolite (M1: 5-HT3 receptor antagonist) significantly inhibited gastric emptying at doses of 19.2 and 64.1 mg/kg (equimolar to 30 and 100 mg/kg of mosapride, respectively), suggesting that the inhibitory effect by mosapride may be caused at least in part by the 5-HT3 receptor antagonistic effect of M1. These findings show that mosapride has dual role on the gastric emptying and may support the usefulness of mosapride for the therapy of postprandial distress syndrome such as early satiation and postprandial fullness.


Assuntos
Benzamidas/farmacologia , Testes Respiratórios/métodos , Esvaziamento Gástrico/efeitos dos fármacos , Morfolinas/farmacologia , Antagonistas do Receptor 5-HT3 de Serotonina , Agonistas do Receptor 5-HT4 de Serotonina , Ácido Acético , Animais , Benzamidas/antagonistas & inibidores , Benzamidas/metabolismo , Radioisótopos de Carbono , Depressão Química , Relação Dose-Resposta a Droga , Indóis/farmacologia , Masculino , Morfolinas/antagonistas & inibidores , Morfolinas/metabolismo , Compostos Radiofarmacêuticos , Ratos , Ratos Sprague-Dawley , Receptor Muscarínico M1 , Antagonistas do Receptor 5-HT4 de Serotonina/farmacologia , Estimulação Química , Sulfonamidas/farmacologia
10.
Biosci Biotechnol Biochem ; 77(9): 1879-81, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24018664

RESUMO

We have reported an inhibitory effect of Lactobacillus gasseri OLL2809 (OLL2809) on the growth of mouse endometrial tissue in the abdominal cavity. The present study aimed to investigate the efficacy of Lactobacillus gasseri OLL2809 (OLL2809) on pre-existing endometriosis implanted on the abdominal wall in diestrus Wistar-Imamichi female rats. One week after implantation, the volume of the endometrial tissue was measured after laparotomy. OLL2809 and dienogest were administered for 4 weeks. OLL2809 significantly enhanced the decrease in the volume (p<0.01) as compared with control. Complete healing was observed in two of nine rats, but in none of the control group. Dienogest did not show significant efficacy. These findings suggest that OLL2809 is useful not only in therapy of pre-existing endometriosis but also in the prevention of the growth of endometrial tissue.


Assuntos
Endometriose/microbiologia , Lactobacillus/fisiologia , Animais , Endometriose/etiologia , Endometriose/patologia , Endometriose/terapia , Endométrio/microbiologia , Endométrio/patologia , Feminino , Ratos , Ratos Wistar
11.
Front Pharmacol ; 13: 692437, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35935877

RESUMO

We investigated the effect of increased pH induced by acid suppressants on the viability of non-Helicobacter pylori helicobacters (NHPHs) within parietal cell intracellular canaliculi and fundic glandular lumina by immunohistochemistry, electron microscopy, quantitative PCR, urea breath tests, and using a bilayer culture system. Three months before the experiment, mice were infected with the NHPH H. suis and then treated with famotidine (2 mg/kg body weight [BW], once daily), lansoprazole (30 mg/kg BW, once daily), or vonoprazan (20 mg/kg BW, once daily) for 3 days. Immunohistochemical studies using the TUNEL method, quantitative PCR analysis, and urea breath tests were performed. PCR analysis showed a decrease in the NHPH quantity after vonoprazan treatment. Urea breath tests revealed a significant decrease in the NHPH urease activity after vonoprazan, lansoprazole, and famotidine treatments for 3 days; however, 4 days after the treatment, urease activity reversed to the pretreatment level for each treatment group. Electron microscopy revealed an increase in the damaged NHPH after vonoprazan treatment. The TUNEL method revealed apoptotic NHPH within parietal cells after vonoprazan treatment. The bilayer culture results demonstrated that NHPH moved more quickly at a pH of 4.0 than at a pH of 3.0, 5.0, and 6.5, and electron microscopy revealed a change from the spiral form to the coccoid form under near-neutral pH conditions. We thus proposed that acid suppressants, especially vonoprazan, induce NHPH damage by altering pH.

12.
Br J Nutr ; 105(1): 10-4, 2011 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-20807468

RESUMO

We evaluated the absorption and metabolism of palatinose in rats by the carbohydrate load test and the 13C- and H2-breath tests. We compared the results of these tests with those of sucrose, since sucrose is an isomer of palatinose and generally known to be degraded and absorbed from the small intestine. In the carbohydrate load test, blood glucose and plasma insulin levels after oral administration of palatinose rose more gradually and reached a maximum that was lower than that after sucrose administration. In the 13C-breath test, rats were orally administrated [1-13C]sucrose or [1-13C]palatinose and housed in a chamber. The expired air in the chamber was collected, and the level of 13CO2 in the expired air was measured at appropriate intervals for 360 min. The value of time taken to reach the maximum concentration for expired 13CO2 from [1-13Cglucose] ([1-13Cglc]) and [1-13Cfructose] ([1-13Cfru]) palatinose was significantly longer than that from [1-13Cglc] and [1-13Cfru]sucrose, respectively. The value of area under the curve (AUC) for [1-13Cglc]palatinose was larger than that for [1-13Cglc]sucrose, but AUC for [1-13Cfru] showed no difference between palatinose and sucrose. In the H2-breath test, the concentration of H2 in the expired air was measured for 420 min. H2 was hardly detected with both palatinose and sucrose and no significant difference was observed between the two groups. These results suggest that palatinose is utilised in vivo at a rate equal to that of sucrose.


Assuntos
Glicemia/metabolismo , Sacarose Alimentar/farmacocinética , Insulina/sangue , Intestino Delgado/metabolismo , Isomaltose/análogos & derivados , Administração Oral , Animais , Área Sob a Curva , Testes Respiratórios/métodos , Dióxido de Carbono/metabolismo , Isótopos de Carbono , Sacarose Alimentar/metabolismo , Hidrogênio/metabolismo , Absorção Intestinal , Isomaltose/metabolismo , Isomaltose/farmacocinética , Masculino , Ratos , Ratos Sprague-Dawley , Sacarose/metabolismo , Sacarose/farmacocinética
13.
J Pharmacol Sci ; 117(1): 63-6, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21836374

RESUMO

Trypsin-treated ß-lactoglobulin significantly decreased the glucose level after an oral glucose tolerance test using mice. We performed the present study to identify the active peptide inhibiting dipeptidyl peptidase-4 from trypsin-treated ß-lactoglobulin. Trypsin-treated ß-lactoglobulin showed a concentration-dependent inhibition for dipeptidyl peptidase-4, with an IC(50) value of 210 µM, although non-treated ß-lactoglobulin showed no significant effect in the in vitro assay. The active peptide was isolated from trypsin-treated ß-lactoglobulin and identified as the hexapeptide Val-Ala-Gly-Thr-Trp-Tyr (ß-lactoglobulin f15-20). This hexapeptide also exhibited a concentration-dependent inhibitory effect and IC(50) value was 174 µM, suggesting that this hexapeptide is almost totally responsible for the DPP-4 inhibitory activity of trypsin-treated ß-lactoglobulin.


Assuntos
Dipeptidil Peptidase 4/efeitos dos fármacos , Lactoglobulinas/farmacologia , Inibidores de Proteases/farmacologia , Lactoglobulinas/química , Inibidores de Proteases/química
14.
Regul Toxicol Pharmacol ; 60(2): 249-61, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21406207

RESUMO

Propionibacterium freudenreichii ET-3 culture, a cell-free product of whey fermentation using P. freudenreichii ET-3 (7025), has been shown to promote the growth of Bifidobacteria through the action of 1,4-dihydroxy-2-naphthoic acid (DHNA), and therefore, has potential use in the food and supplement industries. Although currently used as a food ingredient in Japan, the safety of this novel ingredient has not been previously evaluated through traditional toxicity testing. Therefore, here we report the results of standard toxicological testing performed on P. freudenreichii ET-3 culture. In a 4-week oral toxicity study, administration of 6000mg/kg body weight/day P. freudenreichii ET-3 culture was without compound-related adverse effects on clinical signs, body weights, food consumption, ophthalmology, hematology, clinical chemistry, urinalysis, organ weights, and gross and microscopic findings in male and female Sprague-Dawley rats. Furthermore, in vitro mutagenicity testing demonstrated that P. freudenreichii ET-3 culture was non-mutagenic in the bacterial reverse mutation assay using a standard battery of bacterial strains (Salmonella typhimurium TA98, TA100, TA1535, and TA1537 and Escherichia coli WP2 uvrA) and non-clastogenic in Chinese hamster lung cells in the mammalian chromosome aberration test. Together, the results of these studies support the safety of P. freudenreichii ET-3 culture for use in foods for human consumption.


Assuntos
Testes de Mutagenicidade/métodos , Propionibacterium/metabolismo , Testes de Toxicidade/métodos , Animais , Bifidobacterium/crescimento & desenvolvimento , Células Cultivadas , Aberrações Cromossômicas , Cricetinae , Cricetulus , Meios de Cultura , Feminino , Fermentação , Pulmão/metabolismo , Masculino , Ratos , Ratos Sprague-Dawley
15.
Regul Toxicol Pharmacol ; 60(2): 262-7, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21172397

RESUMO

Propionibacterium freudenreichii ET-3 (7025) culture, a cell-free product of whey fermentation by P. freudenreichii ET-3, has been shown to promote the growth of Bifidobacteria through the action of 1,4-dihydroxy-2-naphthoic acid (DHNA). Here we report the results of two clinical studies designed to evaluate the safety of high doses of P. freudenreichii ET-3 culture medium. Study 1 had a randomized, double-blind, crossover design. Ten healthy male and four healthy female subjects received 45 tablets of either P. freudenreichii ET-3 culture medium (total daily intake of 3g solid content and 283.5µg of DHNA; active group) or placebo (unfermented product) during two 1-week supplementation periods separated by a 4-week washout period. In Study 2, 11 healthy men took four tablets of P. freudenreichii ET-3 culture medium per day (total daily intake of 0.267g solid content and 22.5µg of DHNA) for a period of 13weeks. In both studies, hematological, clinical chemistry, and urinary parameters were measured before and after each supplementation period and gastrointestinal symptoms were assessed by questionnaire. In Study 1, there were no statistically significant differences between placebo and active supplementation periods in any measured parameter and the incidence of gastrointestinal symptoms were similar between groups. In Study 2, total protein, white blood cell count, hemoglobin, and mean corpuscular hemoglobin concentration decreased significantly from baseline and mean corpuscular volume and urine pH increased from baseline. The changes in hematological parameters were deemed not to be due to P. freudenreichii ET-3 culture medium supplementation given that all parameters remained within normal ranges and were not consistent with any clinically meaningful effect.


Assuntos
Suplementos Nutricionais/efeitos adversos , Naftóis/efeitos adversos , Propionibacterium/metabolismo , Adulto , Bifidobacterium/crescimento & desenvolvimento , Estudos Cross-Over , Meios de Cultura , Método Duplo-Cego , Feminino , Fermentação , Humanos , Masculino , Pessoa de Meia-Idade , Naftóis/administração & dosagem , Inquéritos e Questionários , Comprimidos , Adulto Jovem
16.
Biol Pharm Bull ; 33(12): 2029-32, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-21139246

RESUMO

We recently reported that some dibenzoylmethane (DBM) derivatives have a protective effect against endoplasmic reticulum (ER) stress and inhibit nuclear factor kappa B (NF-κB). The aim of this study was to evaluate the effect of DBM derivatives against dextran sulfate sodium (DSS)-induced colitis in mice. The DBM derivatives used in this study were 4,4'-dibromodibenzoylmethane that protects against ER stress, and, 4,4'-dichlorodibenzoylmethane that protects against ER stress and inhibits NF-κB. In each group, the presence of faecal occult blood, the disease activity index score (DAI score) and intestinal length were examined. Both of the DBM derivatives with protective effects against ER stress significantly improved occult bleeding of the colitis induced by DSS. The 4,4'-dichlorodibenzoylmethane significantly reduced the DAI score and inhibited the shortening of colon length, but the 4,4'-dibromodibenzoylmethane did not. These findings suggest that both the protective effect against ER stress and inhibitory effect on NF-κB are needed in the treatment of DSS-induced colitis. Therefore, the effect of 4,4'-dichlorodibenzoylmethane maybe beneficial in the therapeutic regulation of ulcerative colitis.


Assuntos
Chalconas/uso terapêutico , Colite/tratamento farmacológico , Colo/efeitos dos fármacos , Retículo Endoplasmático/efeitos dos fármacos , NF-kappa B/antagonistas & inibidores , Animais , Chalconas/farmacologia , Colite/induzido quimicamente , Colite/metabolismo , Colo/metabolismo , Sulfato de Dextrana , Modelos Animais de Doenças , Retículo Endoplasmático/metabolismo , Fezes/química , Feminino , Camundongos , Camundongos Endogâmicos BALB C , NF-kappa B/metabolismo , Sangue Oculto , Índice de Gravidade de Doença
17.
Biosci Biotechnol Biochem ; 74(9): 1891-4, 2010.
Artigo em Inglês | MEDLINE | ID: mdl-20834166

RESUMO

We have reported that LG21 yogurt containing Lactobacillus gasseri OLL 2716 (LG21 yogurt) inhibits the formation of HCl-induced acute gastric lesions through the generation of prostaglandin E2. This study aimed to determine the role of viable Lactobacillus in the healing of acetic acid-induced chronic gastric ulcer. LG21 yogurt or γ-ray radiated LG21 yogurt was administered orally twice a day for 10 d at a dose of 5 ml/kg. LG21 yogurt significantly accelerated the healing of the ulcer, but γ-ray radiated LG21 yogurt did not. However, both yogurts significantly inhibited HCl-induced gastric erosive lesions and enhanced the generation of gastric mucosal prostaglandin E2. From the above results, it was found that viable bacteria are needed to accelerate the healing of chronic gastric ulcer, but not to inhibit gastric lesions.


Assuntos
Lactobacillus , Probióticos/uso terapêutico , Úlcera Gástrica/terapia , Cicatrização , Iogurte/microbiologia , Ácido Acético/efeitos adversos , Animais , Dinoprostona/biossíntese , Raios gama , Mucosa Gástrica/metabolismo , Ácido Clorídrico/efeitos adversos , Ratos , Úlcera Gástrica/induzido quimicamente , Úlcera Gástrica/prevenção & controle
18.
Acta Crystallogr F Struct Biol Commun ; 74(Pt 4): 214-221, 2018 04 01.
Artigo em Inglês | MEDLINE | ID: mdl-29633969

RESUMO

Proliferating cell nuclear antigen (PCNA) provides a molecular platform for numerous protein-protein interactions in DNA metabolism. A large number of proteins associated with PCNA have a well characterized sequence termed the PCNA-interacting protein box motif (PIPM). Another PCNA-interacting sequence termed the AlkB homologue 2 PCNA-interacting motif (APIM), comprising the five consensus residues (K/R)-(F/Y/W)-(L/I/V/A)-(L/I/V/A)-(K/R), has also been identified in various proteins. In contrast to that with PIPM, the PCNA-APIM interaction is less well understood. Here, the crystal structure of PCNA bound to a peptide carrying an APIM consensus sequence, RFLVK, was determined and structure-based interaction analysis was performed. The APIM peptide binds to the PIPM-binding pocket on PCNA in a similar way to PIPM. The phenylalanine and leucine residues within the APIM consensus sequence and a hydrophobic residue that precedes the APIM consensus sequence are crucially involved in interactions with the hydrophobic pocket of PCNA. This interaction is essential for overall binding. These results provide a structural basis for regulation of the PCNA interaction and might aid in the development of specific inhibitors of this interaction.


Assuntos
DNA Helicases/química , Fragmentos de Peptídeos/química , Antígeno Nuclear de Célula em Proliferação/química , Motivos de Aminoácidos , Sequência de Aminoácidos , Domínio Catalítico , Cristalização , Cristalografia por Raios X , DNA Helicases/metabolismo , Humanos , Modelos Moleculares , Mutagênese Sítio-Dirigida , Mutação , Fragmentos de Peptídeos/metabolismo , Antígeno Nuclear de Célula em Proliferação/genética , Antígeno Nuclear de Célula em Proliferação/metabolismo , Conformação Proteica , Homologia de Sequência
19.
Biofactors ; 30(2): 105-16, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-18356582

RESUMO

It has been reported that Cordyceps sinensis, a traditional Chinese medicine, has various pharmacological effects. The aim of this study was to clarify the effect of water extract of Cordyceps sinensis (WECS) on osteoclast differentiation in vitro. In mouse bone marrow cells and monocyte/macrophage cell line RAW264.7, WECS dose-dependently inhibited the receptor activator of nuclear factor kappa B (NF-kappaB) ligand (RANKL)-induced osteoclast differentiation by tartrate-resistant acid phosphatase (TRAP) staining. In fact, cytotoxic effect was not observed in the RAW264.7 cells treated with WECS. Moreover, the mRNA expression of osteoclast related genes (calcitonin receptor, cathepsin K, matrix metalloprotease 9 and nuclear factor of activated T cells c1) was also inhibited by WECS. Investigation of inhibitory mechanism by using electrophoretic mobility shift assay (EMSA) and Western blot analysis revealed that WECS inhibited the activation of NF-kappaB through the prevention of IkappaBalpha phosphorylation. In conclusion, the present results demonstrate for the first time that WECS is a potent inhibitor of the RANKL-induced osteoclast differentiation through a mechanism involving the NF-kappaB pathway.


Assuntos
Diferenciação Celular/efeitos dos fármacos , Cordyceps/química , Osteoclastos/efeitos dos fármacos , Ligante RANK/farmacologia , Animais , Células da Medula Óssea/efeitos dos fármacos , Catepsina K , Catepsinas/genética , Células Cultivadas , Expressão Gênica/efeitos dos fármacos , Macrófagos/efeitos dos fármacos , Masculino , Metaloproteinase 9 da Matriz/genética , Camundongos , Camundongos Endogâmicos C57BL , Monócitos/efeitos dos fármacos , NF-kappa B/antagonistas & inibidores , Fatores de Transcrição NFATC/genética , Receptores da Calcitonina/genética
20.
J Smooth Muscle Res ; 53(0): 48-56, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28652516

RESUMO

Background This study aimed to evaluate the effects of the position of an acetic acid-induced gastric ulcer and the effects of prokinetic drugs on gastric emptying. Materials and Methods Male Sprague-Dawley rats were used in this study. Acetic acid ulcers were induced either in the region between the fundus and pylorus on the anterior wall of the stomach or in the glandular region on the greater curvature of the stomach to determine whether there were regional differences in the effect of the ulcers. Gastric emptying was evaluated with a breath test using [1-13C] acetic acid. In addition, the effects of the prokinetic drugs, metoclopramide and mosapride, on gastric emptying were also evaluated. Results Acetic acid induced ulcers in the region between the fundus and pylorus on the anterior wall of the stomach significantly delayed gastric emptying as compared with control rats, but not the acetic acid induced ulcers in the glandular region on the greater curvature of the stomach. Metoclopramide and mosapride did not improve the delayed gastric emptying even at doses that enhanced gastric emptying in normal rats. Conclusion These findings show that gastric emptying is influenced by the position of the ulcer and the region between the fundus and pylorus on the anterior wall plays an important role in gastric emptying. Moreover, it was found that metoclopramide and mosapride do not improve the delayed gastric emptying caused by acetic acid ulcers induced on the anterior wall in the region between the fundus and pylorus.


Assuntos
Benzamidas/farmacologia , Esvaziamento Gástrico/efeitos dos fármacos , Esvaziamento Gástrico/fisiologia , Metoclopramida/farmacologia , Morfolinas/farmacologia , Úlcera Gástrica/fisiopatologia , Ácido Acético , Animais , Testes Respiratórios , Relação Dose-Resposta a Droga , Fundo Gástrico , Cinética , Masculino , Piloro , Ratos Sprague-Dawley , Úlcera Gástrica/induzido quimicamente
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA